|Articles|November 15, 2001
- BioPharm International-11-01-2001
- Volume 14
- Issue 11
Outsourcing Outlook: Truth in Outsourcing
Author(s)Jim Miller, William Bierce
by William Bierce and Jim Miller Is that great deal too good to be true?
Advertisement
Articles in this issue
about 24 years ago
Business Matters: Eclipsed by Catastropheabout 24 years ago
Designs for Bioassays with Plate Location Effectsabout 24 years ago
Liposomes (a Review), Part One: Manufacturing Issuesabout 24 years ago
Simplifying Pharmacologic Analysis with Programmable Scientific SoftwareNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Priority Review of Subcutaneous Lecanemab Signals Shift in Alzheimer’s Treatment Delivery
2
FDA Fast Tracks Innovent’s Trispecific Antibody for Multiple Myeloma
3
HanchorBio–WuXi Biologics Partnership Targets Fusion Protein Development Challenges
4
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
5